Lexicon Pharmaceuticals, Inc. ( LXRX ) was a big mover last session, as its shares rose over 16% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the downtrend for the company since Sep 24, as the stock is now down over 10%.
In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Lexicon Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Other better-ranked biomedical stocks include Halozyme Therapeutics, Inc. ( HALO ), Merrimack Pharmaceuticals, Inc. ( MACK ) and Myriad Genetics Inc. ( MYGN ). All three sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
LEXICON PHARMA (LXRX): Free Stock Analysis Report
MYRIAD GENETICS (MYGN): Free Stock Analysis Report
MERRIMACK PHAR (MACK): Free Stock Analysis Report
HALOZYME THERA (HALO): Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
